Spring 2018 Colloquium

The Psychology Department Colloquium Series presents

Dr. Janet Neisewander
Department of Psychology, Arizona State University

Preclinical testing of medications for psychostimulant use disorders.


Substance use disorders are quite difficult to treat, and even when prolonged abstinence is achieved, there is a persistent risk of relapse. Although research has led to pharmacological approaches aimed at reducing drug intake and/or drug cravings, there is still no safe and effective treatment available for psychostimulant use disorders. In this seminar, I will discuss some of the unique difficulties associated with psychostimulant medications development, followed by recent work in my laboratory on two protein targets that may have therapeutic potential: the dopamine D3 receptor and the serotonin 1B receptor. 

2018.02.21 colloquium flyer